To develop Endo-MedSAM, a uterus-focused adaptation of MedSAM-2 for pelvic MRI in endometriosis, and to systematically evaluate its segmentation performance across institutions and prompting strategies.
Key Findings:
Revise to remove unsupported phrases and ensure all claims are directly sourced.
Clarify that performance was evaluated across different configurations.
Interpretation:
Remove unsupported conclusions about robustness and prompting strategies.
Limitations:
Add any limitations mentioned in the source material.
Conclusion:
Revise to remove unsupported claims about clinical implications.
